Literature DB >> 16479169

HEF1-aurora A interactions: points of dialog between the cell cycle and cell attachment signaling networks.

Elena N Pugacheva1, Erica A Golemis.   

Abstract

Regulated timing of cell division cycles, and geometrical precision in the planar orientation of cell division, are critical during organismal development and remain important for the maintenance of polarized structures in adults. Mounting evidence suggests that these processes are coordinated at the centrosome through the action of proteins that mediate both cell cycle and cell attachment. Our recent work identifying HEF1 as an activator of the Aurora A kinase suggests a novel hub for such integrated signaling. We suggest that defects in components of the machinery specifying the temporal and spatial integration of cell division may induce cancer and other diseases through pleiotropic effects on cell migration, proliferation, apoptosis, and genomic stability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16479169      PMCID: PMC2547350          DOI: 10.4161/cc.5.4.2439

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  135 in total

1.  Regulation of integrin-mediated p130(Cas) tyrosine phosphorylation in human B cells. A role for p59(Fyn) and SHP2.

Authors:  S N Manié; A Astier; N Haghayeghi; T Canty; B J Druker; H Hirai; A S Freedman
Journal:  J Biol Chem       Date:  1997-06-20       Impact factor: 5.157

2.  Centrosome behavior in motile HGF-treated PtK2 cells expressing GFP-gamma tubulin.

Authors:  B A Danowski; A Khodjakov; P Wadsworth
Journal:  Cell Motil Cytoskeleton       Date:  2001-10

3.  Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression.

Authors:  J Zhao; R Pestell; J L Guan
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

4.  Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation.

Authors:  L Geng; C R Burrow; H P Li; P D Wilson
Journal:  Biochim Biophys Acta       Date:  2000-12-15

5.  BCAR1/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas.

Authors:  S van der Flier; C M Chan; A Brinkman; M Smid; S R Johnston; L C Dorssers; M Dowsett
Journal:  Int J Cancer       Date:  2000-09-20       Impact factor: 7.396

6.  Centrosomes have a role in regulating the destruction of cyclin B in early Drosophila embryos.

Authors:  J G Wakefield; J Y Huang; J W Raff
Journal:  Curr Biol       Date:  2000-11-02       Impact factor: 10.834

7.  Human enhancer of filamentation 1, a novel p130cas-like docking protein, associates with focal adhesion kinase and induces pseudohyphal growth in Saccharomyces cerevisiae.

Authors:  S F Law; J Estojak; B Wang; T Mysliwiec; G Kruh; E A Golemis
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

8.  Structure and function of Cas-L, a 105-kD Crk-associated substrate-related protein that is involved in beta 1 integrin-mediated signaling in lymphocytes.

Authors:  M Minegishi; K Tachibana; T Sato; S Iwata; Y Nojima; C Morimoto
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

9.  Coordinate activation of c-Src by SH3- and SH2-binding sites on a novel p130Cas-related protein, Sin.

Authors:  K Alexandropoulos; D Baltimore
Journal:  Genes Dev       Date:  1996-06-01       Impact factor: 11.361

10.  Molecular cloning of a cDNA encoding a phosphoprotein, Efs, which contains a Src homology 3 domain and associates with Fyn.

Authors:  M Ishino; T Ohba; H Sasaki; T Sasaki
Journal:  Oncogene       Date:  1995-12-07       Impact factor: 9.867

View more
  40 in total

Review 1.  Aurora kinases in head and neck cancer.

Authors:  Ranee Mehra; Ilya G Serebriiskii; Barbara Burtness; Igor Astsaturov; Erica A Golemis
Journal:  Lancet Oncol       Date:  2013-09       Impact factor: 41.316

Review 2.  Interdependence of cell attachment and cell cycle signaling.

Authors:  Elena N Pugacheva; Fabrice Roegiers; Erica A Golemis
Journal:  Curr Opin Cell Biol       Date:  2006-08-17       Impact factor: 8.382

Review 3.  Primary Cilia and Coordination of Receptor Tyrosine Kinase (RTK) and Transforming Growth Factor β (TGF-β) Signaling.

Authors:  Søren T Christensen; Stine K Morthorst; Johanne B Mogensen; Lotte B Pedersen
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-06-01       Impact factor: 10.005

Review 4.  Cell migration and metastasis markers as targets of environmental pollutants and the Aryl hydrocarbon receptor.

Authors:  Robert Barouki; Xavier Coumoul
Journal:  Cell Adh Migr       Date:  2010-01-05       Impact factor: 3.405

5.  Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton.

Authors:  Michael S Guerrero; J Thomas Parsons; Amy H Bouton
Journal:  Genes Cancer       Date:  2012-05

6.  NEDD9 depletion destabilizes Aurora A kinase and heightens the efficacy of Aurora A inhibitors: implications for treatment of metastatic solid tumors.

Authors:  Ryan J Ice; Sarah L McLaughlin; Ryan H Livengood; Mark V Culp; Erik R Eddy; Alexey V Ivanov; Elena N Pugacheva
Journal:  Cancer Res       Date:  2013-03-28       Impact factor: 12.701

7.  NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.

Authors:  Rongfeng Shi; Lei Wang; Tao Wang; Junfei Xu; Feiran Wang; Meirong Xu
Journal:  Med Oncol       Date:  2014-01-28       Impact factor: 3.064

8.  The WW-HECT protein Smurf2 interacts with the Docking Protein NEDD9/HEF1 for Aurora A activation.

Authors:  Finola E Moore; Evan C Osmundson; Jennifer Koblinski; Elena Pugacheva; Erica A Golemis; Dipankar Ray; Hiroaki Kiyokawa
Journal:  Cell Div       Date:  2010-09-08       Impact factor: 5.130

9.  Golgi partitioning controls mitotic entry through Aurora-A kinase.

Authors:  Angela Persico; Romina Ines Cervigni; Maria Luisa Barretta; Daniela Corda; Antonino Colanzi
Journal:  Mol Biol Cell       Date:  2010-09-15       Impact factor: 4.138

Review 10.  CAS proteins in normal and pathological cell growth control.

Authors:  Nadezhda Tikhmyanova; Joy L Little; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2009-11-25       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.